POMT1 Antibodies

Santa Cruz Biotechnology delivers a wide array of POMT1 monoclonal antibodies for research focused on understanding POMT1 protein function. POMT1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). POMT1, or protein O-mannosyltransferase 1, carries out essential post-translational modifications of proteins during glycosylation. POMT1 maintains a vital role in muscle development and function, where mutations can lead to congenital muscular dystrophies. Research into POMT1 activity continues to reveal new insights about disease mechanisms and potential therapeutic approaches. Scientists worldwide rely on POMT1 monoclonal antibodies to advance their studies of protein glycosylation and muscle disorders. POMT1 monoclonal antibodies enable detailed examination of cellular pathways and disease processes through multiple experimental methods. Ongoing investigations of POMT1 using Santa Cruz Biotechnology monoclonal antibodies contribute valuable knowledge to help develop treatments for muscular dystrophies and related conditions.